About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Phoenix | 149 Studies

Clinical Trials COPDPhoenix

COPD Clinical Trials in Phoenix

Find 149 clinical trials for copd near Phoenix, Arizona. Connect with research centers in your area.

All COPD trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 149 trials

CompletedGSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary DiseaseThe study will evaluate the dose response, safety, and pharmacokinetics of GSK573719 compared with placebo in subjects with COPD.NCT00950807·Phoenix, Arizona and 18 others CompletedUS Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyThe purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.NCT00515164·Phoenix, Arizona and 7 others CompletedA Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary…NCT02497001·Andalusia, Alabama and 189 others

PreviousPage 2 of 8Next

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy In Subjects With COPD (Chronic Obstructive Pulmonary Disease)This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)NCT00103922·Birmingham, Alabama and 114 others

CompletedStudy in Patients With COPDThe purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drugNCT00215423·Phoenix, Arizona and 6 others

CompletedStudy to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDThis is a Phase III randomized, double-blind, parallel group, multi-center, 24-week lung function study with BFF MDI (320/9.6 μg and 160/9.6 μg) compared to FF MDI 9.6 μg, BD MDI…NCT02766608·Athens, Alabama and 258 others

CompletedA Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)This study compared the lung effects of indacaterol to those of tiotropium in patients with moderate to severe chronic obstructive pulmonary disease (COPD) over a 12 week period.NCT00900731·Birmingham, Alabama and 211 others

CompletedEfficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryThe purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of…NCT02155660·Birmingham, Alabama and 355 others

CompletedEfficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDThe objective of this study is to evaluate the effect of inhaled tiotropium bromide on trough FEV1 and to assess the cardiac effects through 12-lead and Holter ECG monitoring in…NCT00239460·Birmingham, Alabama and 11 others

CompletedAMPLIFY - D6571C00001 Duaklir USA Phase III StudyThis is a multiple dose, randomized, parallel, double-blind, double-dummy, multicenter and multinational Phase III study to determine the efficacy and safety of Aclidinium bromide…NCT02796677·Gulf Shores, Alabama and 162 others

Active not recruitingA Study to Evaluate Solrikitug in Participants With COPD (ZION)A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Solrikitug in…NCT06496620·Birmingham, Alabama and 109 others

CompletedA Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)This is a multicenter, randomized, double-blind, double-dummy, parallel group study.NCT01817764·Jasper, Alabama and 58 others

TerminatedA 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.NCT04636814·Andalusia, Alabama and 459 others

CompletedSurvival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.NCT00268216·Birmingham, Alabama and 458 others

CompletedSafety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to assess the long-term safety and tolerability of inhaled aclidinium bromide/formoterol in patients with moderate to severe, stable chronic…NCT01437540·Birmingham, Alabama and 136 others

CompletedStudy to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyThe purpose of this study is to determine steady-state efficacy and dose response profile and to assess safety and pharmacokinetic profile of nebulized EP-101(SUN101) after 7-day…NCT01426009·Phoenix, Arizona and 10 others

CompletedEfficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPDThis is a trial of 12 weeks of treatment with nebulized SUN-101 using an Investigational eFlow® Closed System (CS) nebulizer in subjects with chronic obstructive pulmonary disease…NCT02347761·Anniston, Alabama and 43 others

CompletedRoflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)To demonstrate the additional benefit of roflumilast when added on to fixed-dose combination (FDC) LABA/ICS in the reduction of exacerbations in subjects with severe to very…NCT01443845·Anniston, Alabama and 337 others

UnknownClinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic BronchitisThis is a prospective, randomized, parallel group, double-blind, sham-controlled, multicenter clinical trial following patients to 2 years.NCT04677465·Birmingham, Alabama and 36 others

CompletedA Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)This is a randomized, double-blind, multi-dose, parallel group trial which will assess the pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects…NCT01168310·Phoenix, Arizona and 22 others

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia